[Federal Register: June 24, 2010 (Volume 75, Number 121)]
[Notices]
[Page 36150]
[DOCID:fr24jn10-96]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

National Highway Traffic Safety Administration

Reports, Forms and Record Keeping Requirements; Agency
Information Collection Activity Under OMB Review

AGENCY: National Highway Traffic Safety Administration, DOT

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.), this notice announces that the Information
Collection Request (ICR) abstracted below has been forwarded to the
Office of Management and Budget (OMB) for review and comment. The ICR
describes the nature of the information collection and its expected
burden. The Federal Register Notice with a 60-day comment period was
published on July 20, 2009 (74 FR 35227).

DATES: Comments must be submitted on or before July 26, 2010.

FOR FURTHER INFORMATION CONTACT: Coleman Sachs, National Highway
Traffic Safety Administration, Office of Vehicle Safety Compliance
(NVS-223), 1200 New Jersey Avenue, SE., Room W43-481, Washington, DC
20590.

SUPPLEMENTARY INFORMATION:

National Highway Traffic Safety Administration

    Title: 49 CFR part 566, Manufacturers' Identification.
    OMB Number: 2127-0043.
    Type of Request: Reinstatement of an information collection for
which OMB approval has expired.
    Affected Public: Business or other for-profit organizations.
    Abstract: If a motor vehicle or item of replacement motor vehicle
equipment contains a defect related to motor vehicle safety or fails to
comply with an applicable Federal motor vehicle safety standard, the
manufacturer is required under 49 U.S.C. 30118 to furnish notification
of the defect or noncompliance to the Secretary of Transportation, as
well as to owners, purchasers, and dealers of the motor vehicle or
replacement equipment, and to remedy the defect or noncompliance
without charge to the owner. To ensure that manufacturers are meeting
these and other responsibilities under the statutes and regulations
administered by NHTSA, the agency issued 49 CFR part 566, Manufacturer
Identification. The regulations in part 566 require manufacturers of
motor vehicles or motor vehicle equipment, other than tires, to which a
Federal motor vehicle safety standard (FMVSS) applies, to submit to
NHTSA, on a one-time basis, identifying information on themselves and
on the products that they manufacture to those standards. The
information must be submitted no later than 30 days after the
manufacturer begins to manufacture motor vehicles or motor vehicle
equipment subject to the FMVSS. No specific form need be used for the
submission of this information. Manufacturers who have previously
submitted identifying information must ensure that the information on
file is accurate and complete by submitting revised information no
later than 30 days after a change in the business that affects the
validity of that information has occurred.
    Estimated Burden Hours: 33.
    Number of Respondents: 200.

ADDRESSES: Send comments, within 30 days, to the Office of Information
and Regulatory Affairs, Office of Management and Budget, 725 17th
Street, NW., Washington, DC 20503, Attention NHTSA Desk Officer.
    Comments are invited on: Whether the proposed collection of
information is necessary for the proper performance of the functions of
the Department, including whether the information will have practical
utility; the accuracy of the Department's estimate of the burden of the
proposed information collection; ways to enhance the quality, utility
and clarity of the information to be collected; and ways to minimize
the burden of the collection of information on respondents, including
the use of automated collection techniques or other forms of
information technology. A Comment to OMB is most effective if OMB
receives it within 30 days of publication.

    Issued on: June 17, 2010.
Claude Harris,
Director, Office of Vehicle Safety Compliance.
[FR Doc. 2010-15292 Filed 6-23-10; 8:45 am]
BILLING CODE 4910-59-P


[Federal Register Volume 81, Number 229 (Tuesday, November 29, 2016)]
[Notices]
[Pages 86031-86033]
[FR Doc No: 2016-28632]

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-79373; File No. SR-Phlx-2016-116]

Self-Regulatory Organizations; NASDAQ PHLX LLC; Notice of Filing
and Immediate Effectiveness of a Proposed Rule Change To Amend the
Allocation of Directed Complex Orders

November 22, 2016.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on November 16, 2016, NASDAQ PHLX LLC (``Phlx'' or ``Exchange'') filed
with the Securities and Exchange Commission (``Commission'') the
proposed rule change as described in Items I and II below, which Items
have been prepared by the Exchange. The Commission is publishing this
notice to solicit comments on the proposed rule change from interested
persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to amend the allocation of Directed Orders as
it relates to Complex Orders.\3\
---------------------------------------------------------------------------

    \3\ A Complex Order is any order involving the simultaneous
purchase and/or sale of two or more different options series in the
same underlying security, priced at a net debit or credit based on
the relative prices of the individual components, for the same
account, for the purpose of executing a particular investment
strategy. Furthermore, a Complex Order can also be a stock-option
order, which is an order to buy or sell a stated number of units of
an underlying stock or ETF coupled with the purchase or sale of
options contract(s). See Exchange Rule 1098.
---------------------------------------------------------------------------

    The text of the proposed rule change is available on the Exchange's
Web site at http://nasdaqphlx.cchwallstreet.com/, at the principal
office of the Exchange, and at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The Exchange has prepared summaries, set forth in
sections A, B, and C below, of the most significant aspects of such
statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The purpose of this rule change is to amend the allocation of
Directed Orders at Rule 1014(g)(viii) to except Directed Complex Orders
from receiving a participation guarantee. A Directed Order is any order
(other than a stop or stop-limit order as defined in Rule 1066) to buy
or sell which has been directed to a particular specialist, RSQT, or
SQT by an Order Flow Provider (``OFP'').\4\
---------------------------------------------------------------------------

    \4\ Phlx Rule 1080(1)(i)(A).
---------------------------------------------------------------------------

    In May 2005 the Exchange adopted rules for Phlx XL that permit
Exchange specialists, Streaming Quote Traders (``SQTs''),\5\ and Remote
Streaming Quote Traders (``RSQTs'') \6\ to receive Directed Orders, and
to provide a participation guarantee to specialists, SQTs and RSQTs
that receive Directed Orders.\7\ Pursuant to Phlx Rule 1080(l)(ii) a
Directed Order will be automatically executed and allocated to those
quotations and orders at the National Best Bid or Offer (``NBBO'') when
the Exchange's disseminated price is at the NBBO at the time of receipt
of the Directed Orders and the member or member organization is quoting
at the Exchange's disseminated price.
---------------------------------------------------------------------------

    \5\ An SQT is an Registered Options Trader (``ROT'') who has
received permission from the Exchange to generate and submit option
quotations electronically in options to which such SQT is assigned.
An SQT may only submit such quotations while such SQT is physically
present on the floor of the Exchange. An SQT may only trade in a
market making capacity in classes of options in which the SQT is
assigned. See Phlx Rule 1014(b)(ii)(A). A ROT is defined in Exchange
Rule 1014(b) as a regular member of the Exchange located on the
trading floor who has received permission from the Exchange to trade
in options for his own account. A ROT includes SQTs and RSQTs as
well as on and off-floor ROTS.
    \6\ An RSQT is an ROT that is a member affiliated with a Remote
Streaming Quote Trader Organization with no physical trading floor
presence who has received permission from the Exchange to generate
and submit option quotations electronically in options to which such
RSQT has been assigned. A qualified RSQT may function as a Remote
Specialist upon Exchange approval. See Phlx Rule 1014(b)(ii)(B).
    \7\ See Securities Exchange Act Release No. 51759 (May 27,
2005), 70 FR 32860 (June 6, 2005). See also Phlx Rule 1014(g)(viii)
(setting forth the automatic trade allocation algorithm for Directed
Orders).
---------------------------------------------------------------------------

    At this time, the Exchange is excepting Directed Complex Orders
from a Directed Orders allocation because the Exchange's system cannot
prevent a participation allocation for Directed Complex Orders when the
Exchange's disseminated best bid or offer is not at the NBBO when the
Directed Complex Order is received. The Exchange may offer a
participation allocation for Directed Complex Orders at a later date by
filing a proposed rule change with the Commission, after it has a
limitation in place to systematically enforce Rule 1080(l)(ii) with
respect to Directed Complex Orders. With this proposal, Complex Orders
may continue to be marked as Directed Orders, but these orders will not
receive a participation allocation pursuant to Exchange Rule
1014(g)(viii). Instead, these Complex Orders will be allocated pursuant
to Exchange Rule 1014(g)(vii).
    Today, as noted above, a Directed Order is defined in 1080(1)(i)(A)
as any order (other than a stop or stop-limit order as defined in Rule
1066) to buy or sell which has been directed to a particular
specialist, RSQT, or SQT by an OFP. Pursuant to Exchange Rule 1080(l),
OFPs must transmit Directed Orders to a particular specialist, SQT, or
RSQT electronically. If the Exchange's disseminated best bid or offer
is at the NBBO when the Directed Order is received, the Directed Order
is automatically executed on Phlx XL and allocated to the orders and
quotes represented in the Exchange's quotation. A Directed Specialist,
SQT, or RSQT will receive a participation allocation pursuant to
Exchange Rule 1014(g)(viii) if the Directed Specialist, SQT, or RSQT
was quoting at the NBBO at the time that the Directed Order was
received.\8\ Otherwise, the automatic execution will be allocated to
those quotations and orders at the NBBO pursuant to

Exchange Rule 1014(g)(vii).\9\ Directed Orders can be sent not only on
behalf of public customers but also on behalf of broker dealers.
Directed Orders are limited to orders sent on an agency basis by an OFP
and not on behalf of the sender's proprietary account. To qualify as a
Directed Order, an order must be delivered to the Exchange
electronically. Today, both simple and Complex Orders may be submitted
to the Exchange as Directed Orders and receive an allocation.\10\
---------------------------------------------------------------------------

    \8\ See Exchange Rule 1080(l)(ii).
    \9\ See Exchange Rule 1080(l)(iii).
    \10\ Today, Directed Complex Orders are eligible to receive a
Directed Order allocation only if it is legging into the simple
order book (i.e. the individual components of the Complex Order are
trading against simple orders or quotes). Complex Orders which are
stock-option orders are not eligible to leg into the simple order
book and therefore not eligible to receive a Directed Order
allocation. See Phlx Rule 1098(c)(i).
---------------------------------------------------------------------------

    The Exchange's proposal would result in Directed Complex Orders not
receiving a participation guarantee as a Directed Order pursuant to
Exchange Rule 1014(g)(viii). Directed Simple Orders would continue to
receive a participation guarantee pursuant to Rule 1014(g)(viii).
    The Exchange believes that Directed Orders reward specialists,
SQTs, and RSQTs for actively engaging in marketing activities and
establishing relationships with Order Flow Providers (``OFPs'') that
generate Directed Orders sent to the Exchange by such OFPs. The
Exchange believes that continuing to provide a participation guarantee
for simple orders which are directed, will continue to result in
additional order flow to the Exchange, thus adding depth and liquidity
to the Exchange's markets, and enabling the Exchange to continue to
compete effectively with other options exchanges for order flow. The
Exchange also believes that no longer providing a participation
guarantee when a Directed Complex Order executes will not adversely
impact the market or the opportunity for such orders to execute.
Directed Complex Orders will continue to be provided the same access to
liquidity on the Exchange as today. The Exchange intends to discontinue
the participation allocation prior to December 1, 2016.
2. Statutory Basis
    The Exchange believes that its proposal is consistent with Section
6(b) of the Act,\11\ in general, and furthers the objectives of Section
6(b)(5) of the Act,\12\ in particular, in that it is designed to
promote just and equitable principles of trade, to remove impediments
to and perfect the mechanism of a free and open market and a national
market system, and, in general to protect investors and the public
interest, by continuing to reward specialists, SQTs, and RSQTs
transacting simple options on Phlx XL with a participation guarantee in
trades involving Directed Orders to encourage the capture of order flow
on the Exchange. With this proposal, the Exchange would not permit a
participation guarantee for Directed Complex Orders which are submitted
to the Exchange, nonetheless the Exchange believes continuing to
provide a participation guarantee for simple orders to be directed will
continue to result in additional order flow to the Exchange, thus
adding depth and liquidity to the Exchange's markets, and enabling the
Exchange to continue to compete effectively with other options
exchanges for order flow. Today, the system cannot prevent a
participation allocation for Directed Complex Orders when the
Exchange's disseminated best bid or offer is not at the NBBO when the
Directed Order is received. The Exchange believes that it is consistent
with the Act to not offer the participation allocation for the Directed
Complex Orders without a system limitation in place that would prevent
a Directed Specialist, SQT or RSQT from receiving a Directed Complex
Order allocation pursuant to Exchange Rule 1014(g)(viii) unless the
Directed Specialist, SQT or RSQT is quoting at the NBBO at the time the
Directed Complex Order is received as required by Exchange Rule
1080(l)(ii). The Exchange intended the Directed Order allocation to
reward members and member organizations that are quoting at the NBBO
when a Directed Order is received. The Exchange believes that such a
system limitation would need to be in place to ensure that the
Exchange's Rules related to Directed Complex Order operate as intended.
Since the Exchange does not have the system limitation in place today,
it would not function as intended.
---------------------------------------------------------------------------

    \11\ 15 U.S.C. 78f(b).
    \12\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition not necessary or appropriate in
furtherance of the purposes of the Act. With this proposal, the
Exchange would not provide a participation guarantee for Directed
Complex Orders which are submitted to the Exchange. All Phlx members
and member organizations would continue to receive a participation
guarantee for simple orders directed to the Exchange but not receive a
participation guarantee for Complex Orders that are directed.

B. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    No written comments were either solicited or received.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Because the proposed rule change does not (i) significantly affect
the protection of investors or the public interest; (ii) impose any
significant burden on competition; and (iii) become operative for 30
days from the date on which it was filed, or such shorter time as the
Commission may designate, the proposed rule change has become effective
pursuant to Section 19(b)(3)(A) of the Act \13\ and Rule 19b-4(f)(6)
thereunder.\14\
---------------------------------------------------------------------------

    \13\ 15 U.S.C. 78s(b)(3)(A).
    \14\ 17 CFR 240.19b-4(f)(6). As required under Rule 19b-
4(f)(6)(iii), the Exchange provided the Commission with written
notice of its intent to file the proposed rule change, along with a
brief description and the text of the proposed rule change, at least
five business days prior to the date of filing of the proposed rule
change, or such shorter time as designated by the Commission.
---------------------------------------------------------------------------

    A proposed rule change filed under Rule 19b-4(f)(6) normally does
not become operative prior to 30 days after the date of filing.
However, Rule 19b-4(f)(6)(iii) \15\ permits the Commission to designate
a shorter time if such action is consistent with the protection of
investors and the public interest. The Exchange has asked the
Commission to waive the 30-day operative delay to allow the proposal to
become operative prior to December 1, 2016.\16\ As discussed above,
Phlx Rule 1080(l)(ii) allows a Directed Specialist, SQT, or RSQT to
receive a participation allocation pursuant to Phlx Rule 1014(g)(viii)
if the Directed Specialist, SQT, or RSQT was quoting at the NBBO at the
time the Directed Order was received. The Exchange notes that it
intended the Directed Order allocation to reward members and member
organizations that are quoting at the NBBO when a Directed Order is
received. The Exchange states that, at this time, the Exchange is not
able to systematically enforce the requirement in Phlx Rule 1080(l)(ii)
that a Directed Specialist, SQT, or RSQT be quoting a the NBBO at the
time a Directed Complex Order is received to receive a Directed Complex
Order allocation pursuant to Rule 1014(g)(viii). The

Exchange believes that it is necessary to have the ability to
systematically enforce the requirements of Phlx Rule 1080(l)(ii) with
respect to Directed Complex Orders to assure that the Exchange's
Directed Complex Order rules operate as intended. Accordingly, the
Exchange requests a waiver of the 30-day operative delay to allow the
Exchange to discontinue the participation allocation for Directed
Complex Orders prior to December 1, 2016.\17\ The Commission believes
that waiving the 30-day operative delay is consistent with the
protection of investors and the public interest because the proposed
rule change will allow the Exchange to discontinue the participation
allocation for Directed Complex Orders until the Exchange is able to
systematically enforce the requirements of Phlx Rule 1080(l)(ii) with
respect to Directed Complex Orders.\18\ Accordingly, the Commission
designates the proposed rule change to be operative upon filing.\19\
---------------------------------------------------------------------------

    \15\ 17 CFR 19b-4(f)(6)(iii).
    \16\ The Exchange will provide prior notice of the change in the
form of an Options Trader Alert.
    \17\ As noted above, the Exchange may seek to offer a
participation allocation for Directed Complex Orders after the
Exchange has the ability to systematically enforce the requirements
of Phlx Rule 1080(l)(ii) with respect to Directed Complex Orders.
    \18\ The Commission also notes that the Exchange stated that if
it intends to offer a participation allocation for Directed Complex
Orders in the future it will file a proposed rule change with the
Commission.
    \19\ For purposes only of waiving the 30-day operative delay,
the Commission has also considered the proposed rule's impact on
efficiency, competition, and capital formation. See 15 U.S.C.
78c(f).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act. If the Commission
takes such action, the Commission shall institute proceedings to
determine whether the proposed rule should be approved or disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-Phlx-2016-116 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE., Washington, DC 20549-1090.

All submissions should refer to File Number SR-Phlx-2016-116. This file
number should be included on the subject line if email is used. To help
the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for Web site viewing and
printing in the Commission's Public Reference Room, 100 F Street NE.,
Washington, DC 20549, on official business days between the hours of
10:00 a.m. and 3:00 p.m. Copies of the filing also will be available
for inspection and copying at the principal office of the Exchange. All
comments received will be posted without change; the Commission does
not edit personal identifying information from submissions. You should
submit only information that you wish to make available publicly. All
submissions should refer to File Number SR-Phlx-2016-116 and should be
submitted on or before December 20, 2016.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\20\
---------------------------------------------------------------------------

    \20\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Robert W. Errett,
Deputy Secretary.
[FR Doc. 2016-28632 Filed 11-28-16; 8:45 am]
 BILLING CODE 8011-01-P


[Federal Register Volume 76, Number 163 (Tuesday, August 23, 2011)]
[Notices]
[Pages 52727-52729]
[FR Doc No: 2011-21466]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-65150; File No. SR-NASDAQ-2011-113]

Self-Regulatory Organizations; The NASDAQ Stock Market LLC;
Notice of Filing and Immediate Effectiveness of a Proposed Rule Change
Regarding Clerical Changes to Its Rules

August 17, 2011.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934

(``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on August 5, 2011, The NASDAQ Stock Market LLC (``NASDAQ'' or
``Exchange'') filed with the Securities and Exchange Commission
(``Commission'') the proposed rule change as described in Items I and
II, which Items have been prepared by NASDAQ. The Commission is
publishing this notice to solicit comments on the proposed rule change
from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of the
Substance of the Proposed Rule Change

    NASDAQ proposes to make clerical corrections to correct cross-
references and a typographical error in Rule 5710 of the NASDAQ
rulebook. NASDAQ proposes to implement the proposed rule change
immediately.
    The text of the proposed rule change is available on NASDAQ's Web
site at http://www.nasdaq.cchwallstreet.com, at NASDAQ's principal
office, on the Commission's Web site at http://www.sec.gov, and at the
Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, NASDAQ included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. NASDAQ has prepared summaries, set forth in Sections A,
B, and C below, of the most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    NASDAQ proposes to make clerical corrections to update certain
cross-references in Rule 5710 and correct a typographic error. NASDAQ
inadvertently failed to change these cross-references when the listing
rules were relocated from the Rule 4000 Series of the NASDAQ Rulebook
to the Rule 5000 Series.\3\ This rule filing will correct those cross-
references. In addition, this rule filing will correct a typographic
error in the Rule. The Exchange is not making any substantive changes
to Rule 5710.
---------------------------------------------------------------------------

    \3\ See Securities Exchange Act Release No. 59663 (March 31,
2009), 74 FR 15552 (April 6, 2009) (SR-NASDAQ-2009-018).
---------------------------------------------------------------------------

2. Statutory Basis
    NASDAQ believes that the proposed rule change is consistent with
the provisions of Section 6 of the Act,\4\ in general, and with Section
6(b)(5) of the Act,\5\ in particular, in that the proposal is designed
to prevent fraudulent and manipulative acts and practices, to promote
just and equitable principles of trade, to foster cooperation and
coordination with persons engaged in regulating, clearing, settling,
processing information with respect to, and facilitating transactions
in securities, to remove impediments to and perfect the mechanism of a
free and open market and a national market system, and, in general, to
protect investors and the public interest. The proposed rule change is
consistent with these provisions in that it will eliminate confusion
about NASDAQ rules by updating inaccurate cross-references to rules
that have been renumbered, without changing the substance of the rules.
---------------------------------------------------------------------------

    \4\ 15 U.S.C. 78f.
    \5\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    NASDAQ does not believe that the proposed rule change will result
in any burden on competition that is not necessary or appropriate in
furtherance of the purposes of the Act, as amended.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants or Others

    Written comments were neither solicited nor received.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Pursuant to Section 19(b)(3)(A) of the Act \6\ and Rule 19b-4(f)(3)
thereunder,\7\ NASDAQ has designated this proposal as one that is
concerned solely with the administration of the self-regulatory
organization. Accordingly, NASDAQ believes this proposal should become
immediately effective.
---------------------------------------------------------------------------

    \6\ 15 U.S.C. 78s(b)(3)(A).
    \7\ 17 CFR 240.19b-4(f)(3).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of such proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an e-mail to<EMAIL_ADDRESS>Please include
File Number SR-NASDAQ-2011-113 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington DC 20549-1090.

All submissions should refer to File Number SR-NASDAQ-2011-113. This
file number should be included on the subject line if e-mail is used.
To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments,
all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than those that may be withheld from the public in accordance
with the provisions of 5 U.S.C. 552, will be available for Web site
viewing and printing in the Commission's Public Reference Room, 100 F
Street, NE., Washington, DC 20549, on official business days between
the hours of 10 a.m. and 3 p.m. Copies of such filing also will be
available for inspection and copying at the principal office of the
Exchange. All comments received will be posted without change; the
Commission does not edit personal identifying information from
submissions. You should submit only information that you wish to make
available publicly. All submissions should refer to File No. SR-NASDAQ-
2011-113 and should be submitted on or before September 13, 2011.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\8\
Elizabeth M. Murphy,
Secretary.
---------------------------------------------------------------------------

    \8\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

[FR Doc. 2011-21466 Filed 8-22-11; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 77, Number 22 (Thursday, February 2, 2012)]
[Notices]
[Pages 5283-5284]
[FR Doc No: 2012-2231]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-66261; File No. SR-CME-2012-02]

Self-Regulatory Organizations; Chicago Mercantile Exchange, Inc.;
Notice of Filing and Immediate Effectiveness of Proposed Rule Change
Regarding Fees for Its Cleared-only OTC FX Clearing Offering

January 26, 2012.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on January 24, 2012, Chicago Mercantile Exchange Inc. (``CME'') filed
with the Securities and Exchange Commission (``Commission'') the
proposed rule change described in Items I, II and III below, which
items have been prepared primarily by CME. CME filed the proposed rule
change pursuant to Section 19(b)(3)(A) \3\ of the Act and Rule 19b-
4(f)(2) \4\ thereunder.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ 15 U.S.C. 78s(b)(3)(A).
    \4\ 17 CFR 240.19b-4(f)(2).
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of Terms of Substance of
the Proposed Rule Change

    CME is proposing to make certain fee-related changes that would
apply to its cleared-only OTC foreign exchange (``FX'') swap clearing
offering. The text of the proposed changes \5\ is as follows:
---------------------------------------------------------------------------

    \5\ The text of the proposed changes does not appear in CME's
rulebook but is available on CME's Web site at http://www.cmegroup.com/market-regulation/rule-filings.html.
---------------------------------------------------------------------------

CME OTC FX Fee Waiver Program

Program Purpose

    The purpose of this Program is to incentivize market
participants to submit transaction in the OTC FX products listed
below to the Clearing House for clearing. The resulting increase in
volume benefits all participant segments in the market.

Product Scope

    The following cleared only OTC FX products (``Products''):

1. CME Cleared OTC FX--Emerging Markets

    a. USDBRL, USDCLP, USDCNY, USDCOP, USDIDR, USDINR, USDKRW,
USDMYR, USDPEN, USDPHP, USDRUB, USDTWD Non-Deliverable Forwards
    b. USDCZK, USDHUF, USDHKD, USDILS, USDMXN, USDPLN, USDSGD,
USDTHB, USDTRY, USDZAR Cash-Settled Forwards

2. CME Cleared OTC FX--Majors

    a. AUDJPY, AUDUSD, CADJPY, EURAUD, EURCHF, EURGBP, EURJPY,
EURUSD, GBPUSD, NZDUSD, USDCAD, USDCHF, USDDKK, USDJPY, USDNOK,
USDSEK Cash-Settled Forwards.

Eligible Participants

    The temporary reduction in fees will be open to all market
participants and will automatically be applied to any transaction in
the Products submitted to the Clearing House for clearing.

Program Term

    Start date is February 1, 2012. End date is June 30, 2012.

Hours

    The Program will be applicable regardless of the transaction
time.

Program Incentives

    Fee Waivers. All market participants that clear the Products
will have their clearing fees waived.
* * * * *

    The text of the proposed changes is also available at the
Exchange's Web site at http://www.cmegroup.com, at the principal office
of the Exchange, and at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, CME included statements
concerning the purpose and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. CME has prepared summaries, set forth in sections A, B,
and C below, of the most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of Purpose of, and
Statutory Basis for, the Proposed Rule Change

    CME currently offers clearing for certain cleared-only OTC FX swap
products. The filing proposes to implement a fee waiver program that
will apply to the following cleared-only OTC FX products
(``Products''):

1. CME Cleared OTC FX--Emerging Markets

    a. USDBRL, USDCLP, USDCNY, USDCOP, USDIDR, USDINR, USDKRW,
USDMYR, USDPEN, USDPHP, USDRUB, USDTWD Non-Deliverable Forwards
    b. USDCZK, USDHUF, USDHKD, USDILS, USDMXN, USDPLN, USDSGD,
USDTHB, USDTRY, USDZAR Cash-Settled Forwards

2. CME Cleared OTC FX--Majors

    a. AUDJPY, AUDUSD, CADJPY, EURAUD, EURCHF, EURGBP, EURJPY,
EURUSD, GBPUSD, NZDUSD, USDCAD, USDCHF, USDDKK, USDJPY, USDNOK,
USDSEK Cash-Settled Forwards.

    The fee waiver will be open to all market participants and will
automatically be applied to any transaction in the Products submitted
to CME's clearinghouse for clearing. The proposed changes that are the
subject of this filing are related to the fees CME charges for clearing
and therefore will become effective upon filing. However, the changes
will become operative on February 1, 2012.
    Pursuant to Commodity Futures Trading Commission (``CFTC'')
regulations, the proposed changes are subject to CFTC Regulation
40.6(d), requiring a self-certification filing to the CFTC, although no
change to text of the CME rulebook is required. CME notes that it has
already certified the proposed changes that are the subject of this
filing to its primary regulator, the CFTC. The text of the CME proposed
changes is set out in Section I above.
    The proposed changes establish or change a member due, fee or other
charge imposed by CME under Section 19(b)(3)(A)(ii) of the Securities
Exchange Act of 1934 and Rule 19b-4(f)(2) thereunder. CME believes that
the proposed changes are consistent with the requirements of the
Securities Exchange Act of 1934 and the rules and regulations
thereunder and, in particular, to 17A(b)(3)(iv), in that it provides
for the equitable allocation of reasonable dues, fees and other charges
among participants. CME notes that it operates in a highly competitive
market in which market participants can readily direct business to
competing venues.

B. Self-Regulatory Organization's Statement on Burden on Competition

    CME does not believe that the proposed rule change will have any
impact, or impose any burden, on competition.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    CME has not solicited, and does not intend to solicit, comments
regarding this proposed rule change. CME has not received any
unsolicited written comments from interested parties.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The foregoing rule change was filed pursuant to Section 19(b)(3)(A)
of the Act and paragraph (f)(2) of Rule 19b-4 and became effective on
filing. At any time within sixty days of the filing of such rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is

necessary or appropriate in the public interest, for the protection of
investors, or otherwise in furtherance of the purposes of the Act.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:
     Electronic comments may be submitted by using the
Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml), or send an email to<EMAIL_ADDRESS>Please include
File No. SR-CME-2012-02 on the subject line.
     Paper comments should be sent in triplicate to Elizabeth
M. Murphy, Secretary, Securities and Exchange Commission, 100 F Street
NE., Washington, DC 20549-1090.

All submissions should refer to File Number SR-CME-2012-02. This file
number should be included on the subject line if email is used. To help
the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for Web site viewing and
printing in the Commission's Public Reference Room, 100 F Street NE.,
Washington, DC 20549 on official business days between the hours of 10
a.m. and 3 p.m. Copies of such filing also will be available for
inspection and copying at the principal office of CME. All comments
received will be posted without change; the Commission does not edit
personal identifying information from submissions. You should submit
only information that you wish to make available publicly. All
submissions should refer to File Number SR-CME-2012-02 and should be
submitted on or before February 23, 2012.

    For the Commission by the Division of Trading and Markets,
pursuant to delegated authority.\6\
---------------------------------------------------------------------------

    \6\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2012-2231 Filed 2-1-12; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 86, Number 202 (Friday, October 22, 2021)]
[Notices]
[Pages 58654-58656]
[FR Doc No: 2021-23043]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2017-0750; FRL-9079-01-OCSPP]

Pesticide Registration Review; Proposed Interim Decisions for
Several Pesticides; Notice of Availability

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the availability of EPA's proposed
interim registration review decisions and opens a 60-day public comment
period on the proposed interim decisions for the following pesticides:
Chlormequat chloride; cycloate; famoxadone, inorganic chlorates,
napropamide, nicarbazin, pyridalyl, and tetraconazole.

DATES: Comments must be received on or before December 21, 2021.

ADDRESSES: Submit your comments, identified by the docket
identification (ID) number for the specific pesticide of interest
provided in the Table in Unit IV., using the Federal eRulemaking Portal
at http://www.regulations.gov. Follow the online instructions for
submitting comments. Do not submit electronically any information you
consider to be Confidential Business

Information (CBI) or other information whose disclosure is restricted
by statute. Additional instructions on commenting or visiting the
docket, along with more information about dockets generally, is
available at http://www.epa.gov/dockets.
    Due to the public health concerns related to COVID-19, the EPA/DC
and Reading Room is closed to visitors with limited exceptions. The
staff continues to provide remote customer service via email, phone,
and webform. For the latest status information on the EPA/DC and docket
access, visit https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT:
    For pesticide specific information, contact: The Chemical Review
Manager for the pesticide of interest identified in the Table in Unit
IV.
    For general information on the registration review program,
contact: Melanie Biscoe, Pesticide Re-Evaluation Division (7508P),
Office of Pesticide Programs, Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone number:
(703) 305-7106; email address: [email protected].

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    This action is directed to the public in general and may be of
interest to a wide range of stakeholders including environmental, human
health, farm worker, and agricultural advocates; the chemical industry;
pesticide users; and members of the public interested in the sale,
distribution, or use of pesticides. Since others also may be
interested, the Agency has not attempted to describe all the specific
entities that may be affected by this action. If you have any questions
regarding the applicability of this action to a particular entity,
consult the Chemical Review Manager for the pesticide of interest
identified in the Table in Unit IV.

B. What should I consider as I prepare my comments for EPA?

    1. Submitting CBI. Do not submit this information to EPA through
regulations.gov or email. Clearly mark the part or all of the
information that you claim to be CBI. For CBI information on a disk or
CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as
CBI and then identify electronically within the disk or CD-ROM the
specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.
    2. Tips for preparing your comments. When preparing and submitting
your comments, see the commenting tips at http://www.epa.gov/dockets/comments.html.
    3. Environmental justice. EPA seeks to achieve environmental
justice, the fair treatment and meaningful involvement of any group,
including minority and/or low-income populations, in the development,
implementation, and enforcement of environmental laws, regulations, and
policies. To help address potential environmental justice issues, the
Agency seeks information on any groups or segments of the population
who, as a result of their location, cultural practices, or other
factors, may have atypical or disproportionately high and adverse human
health impacts or environmental effects from exposure to the pesticides
discussed in this document, compared to the general population.

II. Background

    Registration review is EPA's periodic review of pesticide
registrations to ensure that each pesticide continues to satisfy the
statutory standard for registration, that is, the pesticide can perform
its intended function without unreasonable adverse effects on human
health or the environment. As part of the registration review process,
the Agency has completed proposed interim decisions for all pesticides
listed in the Table in Unit IV. Through this program, EPA is ensuring
that each pesticide's registration is based on current scientific and
other knowledge, including its effects on human health and the
environment.

III. Authority

    EPA is conducting its registration review of the chemicals listed
in the Table in Unit IV pursuant to section 3(g) of the Federal
Insecticide, Fungicide, and Rodenticide Act (FIFRA) and the Procedural
Regulations for Registration Review at 40 CFR part 155, subpart C.
Section 3(g) of FIFRA provides, among other things, that the
registrations of pesticides are to be reviewed every 15 years. Under
FIFRA, a pesticide product may be registered or remain registered only
if it meets the statutory standard for registration given in FIFRA
section 3(c)(5) (7 U.S.C. 136a(c)(5)). When used in accordance with
widespread and commonly recognized practice, the pesticide product must
perform its intended function without unreasonable adverse effects on
the environment; that is, without any unreasonable risk to man or the
environment, or a human dietary risk from residues that result from the
use of a pesticide in or on food.

IV. What action is the Agency taking?

    Pursuant to 40 CFR 155.58, this notice announces the availability
of EPA's proposed interim registration review decisions for the
pesticides shown in Table 1 and opens a 60-day public comment period on
the proposed interim registration review decisions.

                   Table 1--Proposed Interim Decisions
------------------------------------------------------------------------
                                                      Chemical review
 Registration review case name    Docket ID No.     manager and contact
            and No.                                     information
------------------------------------------------------------------------
Chlormequat chloride, Case      EPA-HQ-OPP-2015-0  Rachel Stephenson,
 Number 7069.                    816.               [email protected], (703) 347-
                                                    8904.
Cycloate, Case Number 2125....  EPA-HQ-OPP-2015-0  Robert Little,
                                 288.               [email protected],<PHONE_NUMBER>.
Famoxadone, Case Number 7038..  EPA-HQ-OPP-2015-0  Christina Scheltema,
                                 094.               [email protected], (703) 308-
                                                    2201.
Inorganic Chlorates, Case       EPA-HQ-OPP-2016-0  Ana Pinto,
 Number 4049.                    080.               [email protected],
<PHONE_NUMBER>.
Napropamide, Case Number 2450.  EPA-HQ-OPP-2016-0  Carolyn Smith,
                                 019.               [email protected],<PHONE_NUMBER>.
Nicarbazin, Case Number 7628..  EPA-HQ-OPP-2015-0  Samantha Thomas,
                                 101.               [email protected],<PHONE_NUMBER>.
Pyridalyl, Case Number 7451...  EPA-HQ-OPP-2019-0  Rachel Eberius,
                                 378.               [email protected],<PHONE_NUMBER>.

Tetraconazole, Case Number      EPA-HQ-OPP-2015-0  Veronica Dutch,
 7043.                           061.               [email protected],<PHONE_NUMBER>.
------------------------------------------------------------------------

    The registration review docket for a pesticide includes earlier
documents related to the registration review case. For example, the
review opened with a Preliminary Work Plan, for public comment. A Final
Work Plan was placed in the docket following public comment on the
Preliminary Work Plan.
    The documents in the dockets describe EPA's rationales for
conducting additional risk assessments for the registration review of
the pesticides included in the tables in Unit IV, as well as the
Agency's subsequent risk findings and consideration of possible risk
mitigation measures. These proposed interim registration review
decisions are supported by the rationales included in those documents.
Following public comment, the Agency will issue interim or final
registration review decisions for the pesticides listed in Table 1 in
Unit IV.
    The registration review final rule at 40 CFR 155.58(a) provides for
a minimum 60-day public comment period on all proposed interim
registration review decisions. This comment period is intended to
provide an opportunity for public input and a mechanism for initiating
any necessary amendments to the proposed interim decision. All comments
should be submitted using the methods in ADDRESSES and must be received
by EPA on or before the closing date. These comments will become part
of the docket for the pesticides included in the Tables in Unit IV.
Comments received after the close of the comment period will be marked
``late.'' EPA is not required to consider these late comments.
    The Agency will carefully consider all comments received by the
closing date and may provide a ``Response to Comments Memorandum'' in
the docket. The interim registration review decision will explain the
effect that any comments had on the interim decision and provide the
Agency's response to significant comments.
    Background on the registration review program is provided at:
http://www.epa.gov/pesticide-reevaluation.

(Authority: 7 U.S.C. 136 et seq.)

    Dated: October 18, 2021.
Mary Elissa Reaves,
Director, Pesticide Re-Evaluation Division, Office of Pesticide
Programs.
[FR Doc. 2021-23043 Filed 10-21-21; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 78, Number 249 (Friday, December 27, 2013)]
[Notices]
[Page 79035]
[FR Doc No: 2013-30937]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-71152; File No. SR-CBOE-2013-100]

Self-Regulatory Organizations; Chicago Board Options Exchange,
Incorporated; Notice of Designation of a Longer Period for Commission
Action on a Proposed Rule Change Relating to CBSX Trading Permit Holder
Eligibility

December 20, 2013.

I. Introduction

    On October 23, 2013, Chicago Board Options Exchange, Incorporated
(``Exchange'' or ``CBOE'') filed with the Securities and Exchange
Commission (``Commission''), pursuant to Section 19(b)(1) of the
Securities Exchange Act of 1934 (``Act'') \1\ and Rule 19b-4
thereunder,\2\ a proposed rule change regarding eligibility for CBSX
Trading Permit Holders. The proposed rule change was published for
comment in the Federal Register on November 12, 2013.\3\ The Commission
received four comments on the proposal.\4\
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ See Securities Exchange Act Release No. 70806 (November 5,
2013), 78 FR 67424.
    \4\ See letter from Chris Concannon, Executive Vice President,
Virtu Financial BD, LLC, to Elizabeth M. Murphy, Secretary,
Commission, dated November 11, 2013; letter from Martin H. Kaplan,
Gusrae Kaplan Nusbaum PLLC, to Kevin M. O'Neill, Deputy Secretary,
Commission, dated November 18, 2013; letter from James Ongena,
General Counsel, Chicago Stock Exchange, Inc., to Elizabeth M.
Murphy, Secretary, Commission, dated December 3, 2013; and letter
from Mary Ann Burns, Chief Operating Officer, Futures Industry
Association, to Elizabeth M. Murphy, Secretary, Commission, dated
December 3, 2013.
---------------------------------------------------------------------------

    Section 19(b)(2) of the Act \5\ provides that within 45 days of the
publication of notice of the filing of a proposed rule change, or
within such longer period up to 90 days as the Commission may designate
if it finds such longer period to be appropriate and publishes its
reasons for so finding or as to which the self-regulatory organization
consents, the Commission shall either approve the proposed rule change,
disapprove the proposed rule change, or institute proceedings to
determine whether the proposed rule change should be disapproved. The
45th day for this filing is December 27, 2013.
---------------------------------------------------------------------------

    \5\ 15 U.S.C. 78s(b)(2).
---------------------------------------------------------------------------

    The Commission is hereby extending the 45-day period for Commission
action on the proposed rule change. The Commission has determined that
it is appropriate to designate a longer period within which to take
action on the proposed rule change. In particular, the extension of
time will ensure that the Commission has sufficient time to consider
and take action on CBOE's proposal in light of, among other things, the
comments received on the proposal and the Exchange's forthcoming
response to the comments.
    Accordingly, pursuant to Section 19(b)(2)(A)(ii)(I) of the Act \6\
and for the reasons stated above, the Commission designates February
10, 2014, as the date by which the Commission should either approve or
disapprove, or institute proceedings to determine whether to
disapprove, the proposed rule change File No. SR-CBOE-2013-100.
---------------------------------------------------------------------------

    \6\ 15 U.S.C. 78s(b)(2)(A)(ii)(I).

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\7\
---------------------------------------------------------------------------

    \7\ 17 CFR 200.30-3(a)(31).
---------------------------------------------------------------------------

Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2013-30937 Filed 12-26-13; 8:45 am]
BILLING CODE 8011-01-P